In a groundbreaking announcement, Labour has committed to meeting all NHS cancer waiting time targets, a goal that has eluded the health service for over a decade. The ambitious 10-year National Cancer Plan aims to enhance survival rates and streamline diagnosis and treatment processes, ensuring that more patients receive timely and effective care.
Aiming High: Key Targets for Cancer Care
The new plan, set to be detailed further on Wednesday, outlines a series of targets designed to significantly improve cancer care across the UK. By 2029, the government aims for 75% of patients diagnosed from 2025 to be cancer-free or living well five years post-diagnosis, rising from the current figure of 60%.
Additionally, the plan includes:
– Diagnosing or ruling out cancer within 28 days for 75% of patients.
– Ensuring that 96% of patients begin treatment within 31 days following a decision from their doctor.
– Treating 85% of patients within 62 days of a referral.
Health and Social Care Secretary Wes Streeting, a kidney cancer survivor himself, emphasised the importance of equitable cancer care, stating, “Cancer survival shouldn’t come down to who won the lottery of life. But cancer is more likely to be a death sentence in Britain than in other countries around the world.”
Enhancements in Technology and Personalised Treatments
A crucial aspect of this initiative is the proposed increase in robotic-assisted procedures and genomic testing. The government plans to ramp up the use of robotic surgeries from 70,000 to half a million by 2035, with an additional 9.5 million cancer tests to be conducted by 2029. These advancements are aimed at providing more personalised treatment options, allowing healthcare professionals to tailor therapies based on the unique genetic makeup of a patient’s cancer.
Streeting asserts that modern medical science and technology provide an opportunity to transform the prospects of cancer patients in the UK. He stated, “Our cancer plan will invest in and modernise the NHS, so that opportunity can be seized and our ambitions realised.”
Challenges Ahead: Workforce and Funding Concerns
Despite the optimism surrounding the plan, experts have raised concerns regarding the feasibility of these ambitious targets without significant investment and workforce expansion. Richard Evans, Chief Executive of the Society of Radiographers, cautioned that the previous cancer strategy lacked proper funding, stating, “Nothing will happen without investment.”
Recent data reveals that the NHS has not met the 62-day treatment target since its introduction in 2000, with only 70% of patients treated within this period as of November 2025. Moreover, improvements in diagnosis times have been slow, with only a 0.1% increase in patients waiting less than 62 days for treatment between April and November 2025.
Sarah Scobie, Deputy Director of Research at the Nuffield Trust, highlighted the difficulties the NHS will face in achieving these targets based on current performance. She noted that to reach the 85% target for treatment within 62 days by March 2029, the NHS would need to improve its performance by 0.4% each month—a significant challenge given past trends.
Why it Matters
The introduction of this National Cancer Plan represents a pivotal moment for the NHS and cancer care in the UK. As the government aims to enhance patient outcomes and address longstanding issues within the healthcare system, the success of this plan will hinge on the necessary investments in infrastructure, technology, and workforce. Achieving these goals could substantially improve the lives of countless patients and ensure that the UK moves closer to matching the cancer survival rates of other developed nations, ultimately fostering a healthier society.
